データなし
データなし
Fractyl Health To Present New Preclinical Data On Sustained Weight Maintenance And Blood Sugar From Its Rejuva RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate At ObesityWeek 2024
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
Fractyl Health to Present Compelling Weight Maintenance Data From Both Revita and Rejuva Platforms at ObesityWeek 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Fractyl Health to Present at Chardan's 8th Annual Genetic Medicines Conference
Fractyl Health to Participate in Upcoming September Investor Conferences
データなし
データなし